LANTHEUS HOLDINGS, INC.
Climate Impact & Sustainability Data (2022, 2023)
Reporting Period: 2022
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:100% (North Billerica facility)
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Environmental
- Safety
- Diversity, Culture and Community
Environmental Achievements
- Reduced indirect CO2e emissions for North Billerica facility by greater than 99% by exclusively purchasing renewable wind energy.
- Annual waste reductions achieved in lead, radiological waste, wooden pallets, with an increase in mixed recycling and paper shred recycling at North Billerica and Somerset facilities.
Social Achievements
- Began work on a patient registry to understand the real-world benefits of PYLARIFY, with a focus on enrolling a diverse set of patients, particularly African American men.
- Partnered with national prostate cancer advocacy groups and academic centers on several initiatives to address health disparities.
- Developed a robust onboarding program, reinforced company culture and launched development programs for emerging talent.
- Opened a new corporate office designed to foster a collaborative environment for both remote and onsite teams.
- Employee Resource Groups continue to be a strategic enabler of diversity, equity, inclusion and belonging (DEI&B) strategy.
Governance Achievements
- Amended and restated Bylaws in 2022 to implement majority voting in uncontested elections of directors.
- Amended and restated Bylaws in 2021 to implement proxy access rights for stockholders.
- Amended and restated Charter to eliminate certain supermajority voting requirements and to permit holders of at least a majority of common stock to call special meetings of the stockholders.
Climate Goals & Targets
Environmental Challenges
- Reduced site occupancy and changes in manufacturing activities due to the COVID-19 pandemic.
Mitigation Strategies
- Transitioned Pandemic Response Team to a Return to Office Team to plan the safe return of non-critical workforce back to offices.
- Maintained certain COVID-19 policies to ensure a safe work environment and maintain compliance with applicable regulatory agencies.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Supplier Code of Conduct requiring suppliers to operate in an environmentally responsible manner and provide a safe and healthy work environment.
Climate-Related Risks & Opportunities
Awards & Recognition
- Ranked as one of the top women-led businesses in Massachusetts
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Diversity
- Ethics and Compliance
- Environmental Sustainability
- Employee Wellbeing
- Supply Chain Responsibility
Environmental Achievements
- Developed a stormwater management operations and maintenance plan to minimize stormwater pollution.
- Track and monitor energy use, water use, greenhouse gas emissions, and waste generation.
Social Achievements
- Over half of Vice Presidents and above are women.
- Approximately 50% of employees are women.
- Sponsor three Employee Resource Groups.
- Mandatory employee training includes anti-bribery/anti-corruption rules.
- Seek to do business with minority-owned, female-owned, and other diverse businesses.
Governance Achievements
- Formal Ethics and Compliance Committee.
- Supplier Code of Conduct.
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- Competition in the radiopharmaceutical industry.
- Fragile and unstable global supply of Mo-99.
- Dependence on third-party manufacturers and suppliers.
- Potential generic competition for DEFINITY.
- Expiration of TPT Status for PYLARIFY.
- Regulatory uncertainties and changes in healthcare reimbursement policies.
- Cybersecurity threats.
Mitigation Strategies
- Establishing additional PET manufacturing facilities (PMFs).
- Diversifying Mo-99 supply chain.
- Building an in-house manufacturing facility for DEFINITY.
- Actively pursuing patents for PYLARIFY and DEFINITY.
- Advocating for adequate reimbursement for PYLARIFY.
- Investing in cybersecurity services, technologies, and capabilities.
- Comprehensive cybersecurity awareness training for employees.
Supply Chain Management
Supplier Audits: At least annually
Responsible Procurement
- Supplier Code of Conduct
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- PYLARIFY AI presentation awarded Top Rated Oral Presentation at the European Association of Nuclear Medicine meeting